Nanoform Finland
1,762 EUR 0%3.425 investorer følger denne virksomhed
Nanoform Finland is a medical technology company. The company specializes in the research and development of technical products used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. The customers consist of companies in the global pharmaceutical industry. Nanoform Finland mainly operates in the Nordic market and is headquartered in Helsinki.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Finland
NANOFH
Daglig lav / høj pris
1,742 / 1,796
EUR
Markedsværdi
150,7 mio. EUR
Aktieomsætning
17,61 t EUR
Volumen
9,9 t
Seneste videoer
Finanskalender
Delårsrapport
29.08.2024
Delårsrapport
22.11.2024
Årsrapport
27.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Handelsbanken | 7,5 % | 7,5 % |
Edward Hæggström | 6,9 % | 6,9 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Nanoform Finland Plc - Manager's Transactions - Mads Laustsen
Nanoform Finland Plc - Manager's Transactions - Albert Hæggström
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools